J. Michael Pearson
2015 - Valeant Pharmaceuticals International
In 2015, J. Michael Pearson earned a total compensation of $143.1M as Chief Executive Officer at Valeant Pharmaceuticals International, a 1,279% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,000,000 |
|---|---|
| Stock Awards | $140,304,682 |
| Other | $772,760 |
| Total | $143,077,442 |
Pearson received $140.3M in stock awards, accounting for 98% of the total pay in 2015.
Pearson also received $2M in non-equity incentive plan and $772.8K in other compensation.
Rankings
In 2015, J. Michael Pearson's compensation ranked 2nd out of 13,638 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2 out of 13,638 | 100th |
Division Manufacturing | 2 out of 5,187 | 100th |
Major group Chemicals And Allied Products | 2 out of 1,857 | 100th |
Industry group Drugs | 2 out of 1,531 | 100th |
Industry Pharmaceutical Preparations | 1 out of 1,179 | 100th |
Source: SEC filing on April 29, 2016.
Pearson's colleagues
We found six more compensation records of executives who worked with J. Michael Pearson at Valeant Pharmaceuticals International in 2015.
2015
Robert Rosiello
Valeant Pharmaceuticals International
Chief Financial Officer
2015
Anne Whitaker
Valeant Pharmaceuticals International
Group Chairman
2015
Brian Stolz
Valeant Pharmaceuticals International
Senior Vice President and General Manager
2015
Debora Jorn
Valeant Pharmaceuticals International
Group Chairman
2015
Ari Kellen
Valeant Pharmaceuticals International
Group Chairman
2015
Howard Schiller
Valeant Pharmaceuticals International